← Leaderboards
Michael B Maris
Fred Hutchinson Cancer Research Center
$545,669
Attributed
$545,669
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$545,669 · 1
By mechanism
K23$545,669 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Rainer F. Storb$23,835,935
- Effie W Petersdorf$50,293,518
- Brenda Marie Sandmaier$22,185,663
- Paul J Martin$18,480,958
- Claudio Anasetti$8,370,314
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase INeoplasm /Cancer ChemotherapyNeoplasm /Cancer ImmunologyNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Radiation TherapyBlood /Lymphatic NeoplasmGraft Versus Host DiseaseT LymphocyteHuman SubjectHuman Therapy EvaluationMycophenolate MofetilPatient Oriented ResearchStem Cell TransplantationHuman Old Age (65+)Combination Cancer TherapyCyclosporinesFludarabineHematopoietic Tissue TransplantationHistocompatibility AntigensHomologous TransplantationArtificial Immunosuppression
Grant awards (5)
Nonmyeloablative Allografting for Hematologic Neoplasia$77,894
K23 · FY2005 · CA
Nonmyeloablative Allografting for Hematologic Neoplasia$133,650
K23 · FY2004 · CA
Nonmyeloablative Allografting for Hematologic Neoplasia$133,650
K23 · FY2003 · CA
Nonmyeloablative Allografting for Hematologic Neoplasia$66,825
K23 · FY2002 · CA
Nonmyeloablative Allografting for Hematologic Neoplasia$133,650
K23 · FY2001 · CA